Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Aurora Cannabis Inc (ACB) vs Huntington Ingalls Industries Inc (HII) Price & Performance

Aurora Cannabis IncTrade
Huntington Ingalls Industries IncTrade

Price performance (Past 24H)

Key statistics

Aurora Cannabis Inc vs Huntington Ingalls Industries Inc — how do they compare? Aurora Cannabis Inc trades at $3.73 (market cap $223.59M), while Huntington Ingalls Industries Inc trades at $326.15 (market cap $12.92B). The key difference: Huntington Ingalls Industries Inc is far larger — about 57.8× Aurora Cannabis Inc's market cap, and Huntington Ingalls Industries Inc pays a 1.68% dividend while Aurora Cannabis Inc pays none. Which is the better fit depends on your goals.

ACBHII
Market Cap
$223.59M$12.92B
Sector
HealthTechnology
52-Week High
$6.23$453.73
52-Week Low
$2.58$265.40
Enterprise Value
$168.09M$15.84B
Dividend Yield
1.68%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Aurora Cannabis Inc

Aurora Cannabis (ACB) trades at $3.63, up 25.61% amid a hostile takeover bid from Curaleaf at a 45% premium. The stock shows mixed signals with a neutral technical outlook, while fundamentals reveal revenue growth to $343.29M in 2025 but a net income margin of -38.25% and negative ROE. Cash flow improved to a net positive $1.83M in 2025, though 2026 projections indicate renewed losses.

The takeover offer presents a near-term catalyst, but standalone risks persist including profitability challenges and competitive pressures. Analysts are cautious with a majority hold rating. Investors face a binary outcome: accept the premium bid or navigate ACB's volatile fundamentals.

Huntington Ingalls Industries Inc

HII trades at $324.38, down 1.94% on the day, with a bullish technical signal supported by moving averages and strong earnings beats in recent quarters. The company reported Q2 2026 EPS of $5.27, exceeding expectations, and secured a $2.2 billion contract for surveillance capabilities (GlobeNewsWire, August 11, 2026). Valuation ratios include a P/E of 19.53 and P/S of 0.98, indicating reasonable pricing relative to earnings and sales.

Outlook remains positive due to contract wins and margin expansion, but risks include dependence on U.S. defense spending and competitive pressures. The consensus price target of $359.67 suggests upside potential, supported by 44% buy ratings from analysts.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Aurora Cannabis Inc

Aurora Cannabis, based in Edmonton, Canada, grows and distributes both medical and recreational cannabis under several brands, including Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard. While its main market is Canada, the company has also expanded globally through medical cannabis export agreements.

Read more on ACB

About Huntington Ingalls Industries Inc

Huntington Ingalls is the largest military shipbuilder in the U.S. and a provider of professional services to government and industry partners, specializing in nuclear-powered submarines and aircraft carriers.

Read more on HII